We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBE SCIENTIFIC, LLC

Download Mobile App




Microbiologics and Microbix Partner on Viral Controls for Diagnostics

By LabMedica International staff writers
Posted on 12 Apr 2015
Microbiologics, Inc. More...
(St. Cloud, MN, USA) has entered into an agreement to source inactivated viruses from Microbix Biosystems, Inc. (Mississauga, ON, Canada) to be incorporated into a line of full process controls under Microbiologics’ Helix Elite Molecular Standards brand as well as instrument-specific quality control sets.

Diagnostic assays are dependent on controls to demonstrate test performance characteristics and staff proficiency, but laboratories struggle to identify adequate biomaterials and frequently use clinical samples that may not be well characterized or consistently available. Increased regulation requires that labs more carefully consider the source, quality, and format of their molecular and culture-based control materials. This partnership will combine both companies’ expertise in biomaterial development, preservation, and distribution to create highly stable viral controls for molecular testing.

“We are pleased to use Microbix materials in Microbiologics products as they have a strong, global reputation for high-quality viral preparations for the vaccine and immunodiagnostics markets” Brian Beck, PhD, vice president, Molecular Products and Services, Microbiologics, “Incorporation of Microbix viral materials into our lyophilized, molecular-compatible formats complements our existing synthetic standards and extends our catalog to include extraction controls for gastrointestinal, respiratory, blood borne, and sexually transmitted viral pathogens.”

Phil Casselli, senior vice president, Business Development, Microbix, said, “We are pursuing a multipronged approach to exploit the high-growth molecular diagnostics marketplace. Microbiologics has relationships with instrument manufacturers, as well as large-scale distribution capabilities, making them an ideal partner to help expand the reach of our developing molecular program. Our unique isolates offering complements Microbiologics’ strengths. We will both be focused on what we do best in this relationship.”

“As part of our commitment to a safer, healthier world, Microbiologics continues to partner with industry leaders such as Microbix to develop advanced, practical controls that support the evolving field of molecular microbiology,” said Brad Goskowicz, Microbiologics’ CEO, “We look forward to working with molecular diagnostic manufacturers to ensure that clinical laboratories have the appropriate and highest quality control material for their instruments and assays.”

Related Links:
Microbiologics
Microbix Biosystems
Helix Elite, CE-marked IVD molecular standards


Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Whole Blood Control
Lyphochek Whole Blood Control
New
Enterovirus Test
Quanty Enterovirus System
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Ear wax could be a possible screening medium for Parkinson’s disease (Photo courtesy of 123RF)

Earwax Test Accurately Detects Parkinson’s by Identifying Odor Molecules

Current tests for Parkinson’s disease (PD) rely heavily on clinical scales and neuroimaging, which are often subjective, expensive, and ill-suited for routine screening. Since most treatments only slow... Read more

Molecular Diagnostics

view channel
Image: Cord blood proteomics can identify biomarkers of early-onset neonatal sepsis (Photo courtesy of JCI Insight (2025). DOI: 10.1172/jci.insight.193826)

Umbilical Cord Blood Test Can Detect Early Sepsis in Preterm Infants

Diagnosing early onset sepsis (EOS) in preterm infants is particularly difficult due to the lack of specific clinical signs, leading to widespread use of antibiotics while awaiting culture results.... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: NGS can detect one tumor cell among a million healthy cells from a simple blood sample (Photo courtesy of Shutterstock)

New Tool Detects Breast Cancer Relapses Five Years in Advance

Relapse detection in patients with solid tumors—particularly hormone receptor-positive (HR+) breast cancer—remains a major clinical challenge, as many patients initially respond well to treatment but later... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.